Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions explore the reliability of clinical guidelines based on large RCTs versus mechanistic studies, with posts mentioning the 2002 AHA recommendation and negative trial outcomes, showing a balanced engagement that recognizes both the importance of evidence and existing controversies.
Most discussions highlight the importance of rigorous evidence, with some skeptical comments about negative trial results, suggesting general agreement on the cautious interpretation of the research.
The posts focus mainly on clinical guidelines and trial outcomes, indicating moderate interest in the specifics of the publication.
Participants reference guidelines, previous studies, and trial results, demonstrating moderate depth of engagement with the content.
Comments acknowledge the significance of large RCTs and guidelines but do not suggest transformative change, reflecting a moderate perceived impact.
"RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic studies when clinical decisions are being made" understanding this simple idea dispels 90% of social media wellness confusion https://t.co/EKxuQjy0HQ
In 2002, AHA recommended that patients with documented coronary artery disease take ~1 g/d EPA + DHA (after talking to a physician). #CardsJC https://t.co/kwG1N4hYU5
@GopalKkoduru @Angiologist @DLBHATTMD Plenty of negative fish oil trials for secondary prevention or high risk CV patients, almost all of which were negative. Nicely reviewed here, see Table 3: https://t.co/66T8B1eLh6
RT @CardioNerdsJC: In 2002, AHA recommended that patients with documented coronary artery disease take ~1 g/d EPA + DHA (after talking to a…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
This video explores why coentro should not be cooked extensively, the importance of not manipulating research results, and the benefits of Omega-3 fish oil supplementation in preventing cardiovascular disease.
This video explores the Omega-3 Index, a measure of EPA and DHA levels in red blood cells, and its significance as a risk factor for coronary heart disease. Higher levels provide greater protection, making it a valuable…
Sardines have a fascinating history and are rich in nutrients. This video explores how sardines help eliminate poor blood circulation and support overall heart health, backed by scientific evidence on omega-3 fatty…
This video examines the impact of climate change on marine biodiversity. We explore how rising temperatures, ocean acidification, and habitat loss threaten marine ecosystems. Join us to learn about the implications for…
Discover five powerful foods that can help keep your arteries clear, flexible, and healthy. Research indicates that increasing nut intake can significantly reduce the risk of heart disease and improve overall health…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
RT @NutritionMadeS3: "RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic stu…
"RCTs of major disease end points, when available, should trump studies of intermediate end points and mechanistic studies when clinical decisions are being made" understanding this simple idea dispels 90% of social media wellness confusion https://t.co/EKxuQjy0HQ
RT @CardioNerdsJC: In 2002, AHA recommended that patients with documented coronary artery disease take ~1 g/d EPA + DHA (after talking to a…
RT @CardioNerdsJC: In 2002, AHA recommended that patients with documented coronary artery disease take ~1 g/d EPA + DHA (after talking to a…
In 2002, AHA recommended that patients with documented coronary artery disease take ~1 g/d EPA + DHA (after talking to a physician). #CardsJC https://t.co/kwG1N4hYU5
@GopalKkoduru @Angiologist @DLBHATTMD Plenty of negative fish oil trials for secondary prevention or high risk CV patients, almost all of which were negative. Nicely reviewed here, see Table 3: https://t.co/66T8B1eLh6